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Laura Silveira-Moriyama1, Andrew J. Lees2
The Editorial Board of Arquivos de Neuro-Psiquiatria is pleased to announce the opening of a new section, which is entitled “Tricks of the trade/Pulo do gato”. It pro-vides articles from invited authorities in various fields of Neurology who are willing to share their expertise, especially international experts who are keen on collabora-
tions with Latin-American Neuroscience and Clinical Neurology. To open the section we invit-
ed Doctor Sarosh Irani and Professor Angela Vincent from Oxford to write a practical update 
on the exciting field of autoimmune encephalitis. 
Professor Angela Vincent has major contributions to the understanding and the diagnosis 
of various antibody-mediated diseases of the central and peripheral nervous system. She did 
extensive work on myasthenia gravis, including the discovery of MuSK1 antibodies and the de-
velopment of methods to detect the presence of low-affinity IgG anti-acetylcholine receptor 
antibodies2. She also described the association of VGKC-complex antibodies with Morvan’s 
fibrillary chorea3,4, and she later defined the clinical manifestations in cases of limbic encepha-
litis associated with the same antibodies5, and subsequently the actual targets of the antibod-
ies in the brain6. Amongst other things, Vincent also described a novel glycine receptor anti-
body in patients with progressive encephalomyelitis with rigidity and myoclonus7.
In the first “Tricks of the trade”, the invited ones explain the main advances on the un-
derstanding of the pathophysiology of the autoimmune encephalitis and pinpoint the ma-
jor clinical features that differentiate the encephalitis associated with each known antibody. 
Autoimmune encephalitis accounts for a significant proportion of the cases suspected to have 
viral encephalitis, which are negative for the main viral aetiologies, including the classical cas-
es of limbic encephalitis. Most importantly, when readily identified they respond successfully 
to immunotherapies. Therefore, it is of interest to the general neurologist as much as it is to the 
specialist to understand the developments in this rapidly changing field. 
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